CVI Holdings’s Filana Therapeutics FLNA Stock Holding History

CVI Holdings’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-452,246	Closed	-$2.35M	–	44
2019 Q4	$2.35M	Buy	+452,246	New	+$781K	3.31%	10

Other funds holding FLNA

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

CVI Holdings's FLNA Position: Q1 2020 in Review

CVI Holdings sold out of Filana Therapeutics (FLNA) in Q1 2020, closing a stake of 452,246 shares — an estimated $2.35M sold.

CVI Holdings first reported a position in FLNA in Q4 2019 and held it in 1 quarter. The position peaked at $2.35M in Q4 2019. 40 funds tracked by Wall St. Rank hold FLNA as of Q1 2020.

CVI Holdings reported no remaining Filana Therapeutics position as of Q1 2020 after selling out during the quarter.
CVI Holdings sold 452,246 Filana Therapeutics shares in Q1 2020, an estimated $2.35M.
CVI Holdings first reported a position in Filana Therapeutics in Q4 2019 and held it in 1 quarter.
CVI Holdings's Filana Therapeutics position peaked at $2.35M in Q4 2019.
40 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2020.

Based on CVI Holdings's 13F filing for Q1 2020, filed 15 May 2020.